Correlation Between Silo Pharma and Summit Therapeutics

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and Summit Therapeutics PLC, you can compare the effects of market volatilities on Silo Pharma and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Summit Therapeutics.

Diversification Opportunities for Silo Pharma and Summit Therapeutics

0.51

Correlation Coefficient

Silo Pharma  Summit Therapeutics

Very weak diversification

The 3 months correlation between Silo and Summit is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Silo Pharma i.e., Silo Pharma and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Silo Pharma and Summit Therapeutics

Given the investment horizon of 90 days Silo Pharma is expected to generate 1.09 times more return on investment than Summit Therapeutics. However, Silo Pharma is 1.09 times more volatile than Summit Therapeutics PLC. It trades about -0.03 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about -0.04 per unit of risk. If you would invest  105.00  in Silo Pharma on September 25, 2024 and sell it today you would lose (17.00) from holding Silo Pharma or give up 16.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Silo Pharma  vs.  Summit Therapeutics PLC

Silo Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Silo Pharma and Summit Therapeutics

The main advantage of trading using opposite Silo Pharma and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.

The idea behind Silo Pharma and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.